This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1lk3

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
IL-10 is a dimeric cytokine that must engage its high-affinity cell, surface receptor, IL-10R1, to induce multiple cellular activities. Here we, report the 1.9 A crystal structure of an engineered IL-10 monomer, (IL-10M1) in complex with a neutralizing Fab fragment (9D7Fab). 9D7Fab and, IL-10R1 bind distinct nonoverlapping surfaces on IL-10M1. Antagonism of, the IL-10M1/IL-10R1 interaction is the result of 9D7Fab-induced, conformational changes in the CD loop of IL-10M1 that indirectly alter the, structure of the IL-10R1 binding site. A single mutation (Ile87Ala) in the, same CD loop region of the Epstein-Barr virus IL-10 (ebvIL-10) also, reduces IL-10R1 binding affinity, suggesting that ebvIL-10 and 9D7Fab use, similar allosteric mechanisms to modulate IL-10R1 affinity and biological, activity.
+
IL-10 is a dimeric cytokine that must engage its high-affinity cell surface receptor, IL-10R1, to induce multiple cellular activities. Here we report the 1.9 A crystal structure of an engineered IL-10 monomer (IL-10M1) in complex with a neutralizing Fab fragment (9D7Fab). 9D7Fab and IL-10R1 bind distinct nonoverlapping surfaces on IL-10M1. Antagonism of the IL-10M1/IL-10R1 interaction is the result of 9D7Fab-induced conformational changes in the CD loop of IL-10M1 that indirectly alter the structure of the IL-10R1 binding site. A single mutation (Ile87Ala) in the same CD loop region of the Epstein-Barr virus IL-10 (ebvIL-10) also reduces IL-10R1 binding affinity, suggesting that ebvIL-10 and 9D7Fab use similar allosteric mechanisms to modulate IL-10R1 affinity and biological activity.
==Disease==
==Disease==
Line 18: Line 18:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: DiGiacomo, R.]]
[[Category: DiGiacomo, R.]]
-
[[Category: Indelicato, S.R.]]
+
[[Category: Indelicato, S R.]]
-
[[Category: Jones, B.C.]]
+
[[Category: Jones, B C.]]
[[Category: Josephson, K.]]
[[Category: Josephson, K.]]
-
[[Category: Walter, L.J.]]
+
[[Category: Walter, L J.]]
-
[[Category: Walter, M.R.]]
+
[[Category: Walter, M R.]]
[[Category: antigen-antibody complex]]
[[Category: antigen-antibody complex]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:18:53 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:45:43 2008''

Revision as of 11:45, 21 February 2008


1lk3, resolution 1.91Å

Drag the structure with the mouse to rotate

ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT

Contents

Overview

IL-10 is a dimeric cytokine that must engage its high-affinity cell surface receptor, IL-10R1, to induce multiple cellular activities. Here we report the 1.9 A crystal structure of an engineered IL-10 monomer (IL-10M1) in complex with a neutralizing Fab fragment (9D7Fab). 9D7Fab and IL-10R1 bind distinct nonoverlapping surfaces on IL-10M1. Antagonism of the IL-10M1/IL-10R1 interaction is the result of 9D7Fab-induced conformational changes in the CD loop of IL-10M1 that indirectly alter the structure of the IL-10R1 binding site. A single mutation (Ile87Ala) in the same CD loop region of the Epstein-Barr virus IL-10 (ebvIL-10) also reduces IL-10R1 binding affinity, suggesting that ebvIL-10 and 9D7Fab use similar allosteric mechanisms to modulate IL-10R1 affinity and biological activity.

Disease

Known diseases associated with this structure: Graft-versus-host disease, protection against OMIM:[124092], HIV-1, susceptibility to OMIM:[124092], Rheumatoid arthritis, progression of OMIM:[124092]

About this Structure

1LK3 is a Single protein structure of sequence from Homo sapiens and Rattus norvegicus. Full crystallographic information is available from OCA.

Reference

Noncompetitive antibody neutralization of IL-10 revealed by protein engineering and x-ray crystallography., Josephson K, Jones BC, Walter LJ, DiGiacomo R, Indelicato SR, Walter MR, Structure. 2002 Jul;10(7):981-7. PMID:12121653

Page seeded by OCA on Thu Feb 21 13:45:43 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools